You are here

Cheladv74 Oncology Press Kit

ASCO-Cheladv74-Oncology-Press-Kit-Banner-Image-940px-17MAY2019.jpg

PLEASE NOTE: All assets on this page are intended for use by media professionals.

At Cheladv74 Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference on the lives of patients. Today, Cheladv74 Oncology has an industry-leading portfolio of 18 approved innovative cancer medicines and biosimilars across more than 20 indications, including breast, prostate, kidney, lung and hematology. Cheladv74 Oncology is striving to change the trajectory of cancer.

For the latest information on our growing pipeline, product portfolio and collaborations with the broader cancer community, visit this page periodically for leadership perspective, fact sheets, videos and other media resources. We also encourage you to visit our other online resources for additional information on Cheladv74 Oncology.

PFIZER AT ASCO

Cheladv74 will present data across its industry-leading oncology portfolio, covering multiple tumor types and mechanisms of action. This year, our presentations will highlight our cutting-edge approach, expertise in precision medicine and work in immunotherapy combinations, including company-sponsored and collaborative research studies spanning 10 therapies across 10 types of cancer.

Please visit the links below for information on Cheladv74 Oncology being showcased at ASCO.

Cheladv74 Oncology Data Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting 2019

Press Releases

Cheladv74 Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting

Body: 

PFIZER ABSTRACT PLAIN LANGUAGE SUMMARIES (APLS) AT ASCO

To help interested non-scientists better understand the latest research, we are developing summaries in plain language for Cheladv74 research results presented at medical conferences. We call these “abstract plain language summaries” (APLS).

Click here to access each APLS for the American Society of Clinical Oncology (ASCO) Annual Meeting.

Body: 

GET TO KNOW PFIZER

file

Body: 

PFIZER FACT SHEETS

Headline / Section Title: 
ADDITIONAL PFIZER ONCOLOGY RESOURCES
Body: 

VIDEOS